- Article metrics
- Last updated: Thu, 16 Oct 2025 17:13:39 Z
A post-marketing surveillance study of dabrafenib and trametinib combination in Japanese patients with unresectable advanced or recurrent BRAF-mutated NSCLC
Access & Citations
-
- 1381
- Article Accesses
-
- 0
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
